Economy · World
US President Trump Announces Medicaid Drug Pricing Model
US President Donald Trump announced that all 50 states will join a new Medicaid drug pricing model. The policy aims to align US prices for certain Medicare drugs with the lowest prices paid in other developed nations. The initiative, previously referred to as the "Most Favored Nations" policy, seeks to reduce medication costs for American consumers. Concerns have been raised about the specifics and potential implications of these drug pricing deals.
How outlets across the spectrum covered it
L 0 C 2 R 0
- Centre (2): Chicago Tribune, Fortune